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Abstract
Background: The physiological function of the ubiquitous cellular prion protein, PrP
c, is still under debate. It was essentially
studied in nervous system, but poorly investigated in epithelial cells. We previously reported that PrP
c is targeted to cell–cell
junctions of polarized epithelial cells, where it interacts with c-Src.
Methodology/Findings: We show here that, in cultured human enterocytes and in intestine in vivo, the mature PrP
c is
differentially targeted either to the nucleus in dividing cells or to cell–cell contacts in polarized/differentiated cells. By
proteomic analysis, we demonstrate that the junctional PrP
c interacts with cytoskeleton-associated proteins, such as
gamma- and beta-actin, alpha-spectrin, annexin A2, and with the desmosome-associated proteins desmoglein, plakoglobin
and desmoplakin. In addition, co-immunoprecipitation experiments revealed complexes associating PrP
c, desmoglein and c-
Src in raft domains. Through siRNA strategy, we show that PrP
c is necessary to complete the process of epithelial cell
proliferation and for the sub-cellular distribution of proteins involved in cell architecture and junctions. Moreover, analysis of
the architecture of the intestinal epithelium of PrP
c knock-out mice revealed a net decrease in the size of desmosomal
junctions and, without change in the amount of BrdU incorporation, a shortening of the length of intestinal villi.
Conclusions/Significance: From these results, PrP
c could be considered as a new partner involved in the balance between
proliferation and polarization/differentiation in epithelial cells.
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Introduction
The cellular prion protein (PrP
c) is a ubiquitous glycoprotein
anchored to the outer leaflet of the plasma membrane, in raft
domains, through a glycosylphosphatidylinositol (GPI) moiety [1].
Its central role in transmissible spongiform encephalopathies has
been clearly demonstrated for many years [2–4] and efforts have
been made to determine its biological role apart from pathological
situations. Although many cells and tissues, such as blood
lymphocytes, muscle, heart, kidney, digestive tract and skin,
express PrP
c [5–9], most of the studies concerning its physiological
function have been performed on nerve cells. In these models, it
has been established that PrP
c binds copper [10] and can
homodimerize [11] or interact with other proteins, among which
are synapsin Ib, Grb2, Pint1, LRP/LR, and N-CAMs [12–19]. It
has also been reported that PrP
c, via interaction with phosphor-
ylated Fyn [20], participates in cell redox homeostasis through
ROS production [21]. In addition, it has been shown that multiple
biochemical changes occur in prion protein knockout mice. They
include increased levels of NF-kB and COX-IV and decreased
levels of p53 and Cu, Zn superoxide dismutase activity, along with
an increased neuronal sensitivity to oxidative stress in cultured
cells isolated from these mice [22].
Much less is known about the role of PrP
c in extra-neuronal
tissues. In epithelial cells, PrP
c was reported to be directed to
basolateral membranes of MDCK and FRT epithelial cells [23].
¤a
¤b
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c is expressed in enterocytes [24], which
are highly polarized epithelial cells of the intestinal epithelium.
Interestingly, we showed that, in polarized/differentiated enter-
ocytes, PrP
c is targeted to the lateral junctional complexes of
adjacent cells where it interacts with Src kinase [24]. This tyrosine
kinase is known targeted to cell–cell junctions where it phosphor-
ylates substrates that induce adhesion turnover and actin
remodeling [25]. Such a localization of PrP
c, was also observed
in human keratinocytes [24] and in endothelial cells [26], opening
questions about the role of PrP
c in cell–cell junctions of
physiological barriers.
To address this question, we focused our study on intestinal
epithelium and on enterocytes, the major cell population of this
epithelium. Intestinal epithelium undergoes a rapid renewal
throughout life (for review see [27]). Such a process requires a
continuous coordination between proliferation, differentiation and
death programs, along with a remodeling of cell-matrix and cell–
cell contacts responsible for cell polarization. In crypts are
localized stem cells and dividing cells, which migrate up to the
villus where differentiation takes place. In the present work, we
have analyzed whether the sub-cellular localization of PrP
c varied
in relation with cell proliferation, cell polarization and the state of
cell–cell junctions in human intestinal epithelium in vivo and in the
human Caco-2/TC7 enterocytes [28], which reproduce in culture
the sequence of division and polarization/differentiation. In this
enterocyte model, we characterized the partners of PrP
c in cell–
cell junctions. Finally, the impact of the invalidation of PrP
c on the
distribution of cell–cell junctions-associated proteins, the process of
cell proliferation and the morphology of the intestinal epithelium
was analyzed.
Materials and Methods
Reagents
Exceptwhen indicated,allchemicalswerepurchasedfrom Sigma
(Sigma-Aldrich, Saint Quentin Fallavier, France). Mouse 12F10
(against peptide 142–160) and SAF32 (against peptide 79–92) anti-
human PrP
c monoclonal antibodies were obtained from S.P.I BIO
(Montigny le Bretonneux, France). Rabbit anti-human Ki67
polyclonal antibody and rat anti-mouse E-cadherin monoclonal
antibody (ECCD-2) were purchased from Zymed Laboratories (San
Francisco, CA). Rabbit anti-human Src (sc-18), and goat anti-
human poly (ADP-ribose) polymerase (PARP) antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Mouse anti-human calnexin, desmoglein, plakoglobin and annexin
A2 monoclonal antibodies were purchased from BD Biosciences
(Erembodegem, Belgium). Rabbit anti-human PrP
c (Ab 703), anti-
pan desmoglein, anti-desmoplakin, anti phospho-S10-Histone H3
(Ab5176) polyclonal antibodies and rat anti-BrdU monoclonal
antibody were purchased from Abcam (Cambridge, UK). Second-
ary CY2-, CY3- and CY5-labelled antibodies were purchased from
Jackson Immuno-Research (West Grove, PA). F-actin was labelled
with phalloidin-FITC. Endoglycosidase F was purchased from
VWR (Fontenay sous bois, France). The biotinylated pro-aerolysin
bacterial toxin [29] was a kind gift from Gisou van der Goot (Ecole
Polytechnique de Lausanne, CH-1015 Lausanne, Switzerland).
Cell culture
All culture media were purchased from Gibco, Invitrogen Life
Technologies (Cergy Pontoise, France). Caco-2/TC7 cells [28]
were cultured with high glucose DMEM (Dulbecco’s modified
Eagle’s medium) Glutamax I supplemented with 20% heat
inactivated (56uC, 30 min) fetal calf serum (AbCys, Paris, France),
1% non-essential amino acids, penicillin (100 IU/ml) and
streptomycin (10 mg/ml) in a 10% CO2/air atmosphere. The
medium was changed every day. Depending on experiments, cells
were plated on 1 mm pore size microporous PET filters (Falcon,
BD Biosciences, Franklin lakes, NJ), or in plastic flasks (Falcon) or
on glass lamellae (Polylabo, Strasbourg, France).
Cells treatments
Cycloheximide treatment. When indicated, the cells were
treated with cycloheximide (10 mM final concentration).
siRNA transfection. siRNA correspondingto thehuman Prnp
gene from codon 399 to 417 was synthesized by MWG Biotech
(Ebersberg, Germany). The specific human siRNA sequence used
was: 59-GCC-GAG-UAA-GCC-AAA-AAC-CTT-39 (sense). Cells
were seeded at 5000 cell/cm
2 on plastic or glass lamellae. siRNAs
were mixed with Oligofectamine reagent (Invitrogen Life
Technologies) for 15 min and Opti-MEM medium without serum
was added according to the manufacturer’s instructions. The final
concentration of siRNA was 400 nM. After incubation for 6 hours
at 37uC, Opti-MEM supplemented with 60% fetal calf serum was
added to reach a final 20% serum concentration. A mouse PrP
c
siRNA sequence (59-GCC-CAG-CAA-ACC-AAA-AAC-CTT-39),
inefficient on human PrP
c RNA, and a scramble siRNA (59-CCG-
AGA-AGU-AAA-GCC-AAC-CTT-39) were used as controls along
with cells incubated with Oligofectamine reagent only. After 24 h,
the medium was changed for the standard medium and the cells
from all conditions were maintained in culture for the indicated
times, the medium being changed every day.
GFP-PrP
c plasmid construct and cell transfection
pEGFP-mouse PrP
c plasmid [30] was obtained from MA Prado.
GFP-PrP
c was originally under the control of CMV promoter in
this plasmid. To allow the expression of GFP-PrP
c in differentiated
cells, the corresponding sequence was subcloned into pGL2basic
vector (Promega France) under the control of SV40 promoter.
Caco-2/TC7 cells were transfected on day 2 with oligofectamine
(Invitrogen, France) according to the manufacturer’s instructions.
After selection with G418 (Gibco BRL, France), transformed cells
were allowed to expand prior to sorting, on the basis of GFP
fluorescence, in an ALTRA cell sorter (Beckman Coulter, France).
Immunofluorescence analysis
Cells were washed twice with PBS containing 1 mM CaCl2 and
0.5 mM MgCl2, and fixed for 30 min with 4% paraformaldehyde
(wt/vol) in PBS at 4uC. After an extensive washing in 150 mM
glycine in PBS (PBS-glycine), the cells were permeabilized by
incubation for 30 min in 0.1% Triton X-100 in PBS and washed
in PBS-glycine followed by PBS plus 1% BSA. Cells were
incubated for 60 min at room temperature with primary
antibodies in PBS supplemented with 1% BSA, washed with
PBS and stained with secondary antibodies in PBS with 1% BSA
for 60 min at room temperature in the dark. After extensive
washing in PBS, cells were mounted in Fluoprep (BioMe ´rieux,
Marcy l’Etoile, France), and examined by epifluorescence
microscopy (Axiophot microscope connected to Axiocam camera
using Axiovision 4.5 software; Carl Zeiss). Confocal microscopy
(LSM 510 microscope; Carl Zeiss, Jena, Germany) was used for
the observation of cells cultured on microporous filters, which are
strongly autofluorescent and generate excessive background in
epifluorescence. X–Z planes resulted from 0.1 mm stacks.
Tissue analysis
PrP
c knock out mice [2] backcrossed on C57Bl6 and their wild
type C57Bl6 counterparts were purchased from CDTA (Orle ´ans,
PrPc and Epithelial Cells
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c knock out
mice, 2 cm segments of duodenum and jejunum were cut, gently
flushed with PBS and opened longitudinally. Rolled segments were
frozen in cryo-embedding media (OCT) and stored at 280uC until
cryostat sectioning (10–20 mm). Sections were applied onto
gelatine-coated glass slides, fixed in paraformaldehyde solution
(4%), permeabilized with Triton before DAPI staining and then
mounted in fluoprep solution.
Mitotic crypt cells were labeled with an anti-phosphoS10-
Histone H3, using the same protocol as for cell immuno-labeling.
To label proliferating intestinal crypt cells in S-phase, PrP
c knock
out and wild-type C57Bl6 mice were given an intraperitoneal
injection of 5-bromo-29-deoxyuridine (BrdU; Sigma; 120 mg/kg
body weight) 90 min before sacrifice. Paraffin sections of alcohol-
formalin-acetic acid (AFA)-fixed jejunum were incubated for
30 min in 2.5 N HCl before processing for immunofluorescent
labeling with anti-BrdU antibody.
Sections from paraffin-embedded human jejunum were sequen-
tially treated with xylene (265 min), 100% EtOH (265 min), 95%
EtOH (165 min) and then rinsed with water. Antigens retrieval
was performed by boiling slides in 10 mM citrate buffer (pH 6) for
10 min. After washes in PBS, sections were fixed and then the
same protocol as described above for immunofluorescence was
used.
Immunoelectron microscopy
Caco-2/TC7 cells, grown on Thermanox coverslips (Agar
scientific), were fixed with acetone. After incubation with 12F10
monoclonal antibody, gold (1 nm particles)-labelled goat anti
mouse IgG (Amersham Biosciences) were used as secondary
antibodies and the resulting signal was enhanced by the Intense
TM M silver enhancement kit (Amersham Biosciences). After
alcohol-graded dehydratation, sections were embedded in Epon
and ultrathin sections were analyzed (Jeol 100 CX II). For
desmosomal structure analyses, intestine was flushed with cold
0.1 M Phosphate buffer (pH 7.4), ligatured and filled with cold
2.5% glutaraldhehyde/0.5% tannic acid in 0.1M cacodylate buffer
at pH 7.4 for 2H. Fine samples of intestine were cut and fixed by
0.6% glutaraldhehyde/0.5% tannic, which stains and preserve the
ultrastructure of phospholipids [31] in the same buffer overnight at
4uC. Postfixation was carried out in 2% osmic acid in 0.1 M
Phosphate buffer for 1h at 4uC. Samples were then dehydrated in
graded alcohol and embedded in Epon resin (Poly/Bed 812,
Polysciences Inc.Warrington, PA). Ultrathin sections of around
65 nm were counterstained with uranyl acetate (30 min, 40uC)
and lead citrate (10 min, 25uC) using an LKB 2168 ultrostainer.
Observations were made using a JEOL CX100 equipped with a
Gatan Digital camera (3.11.0) and the migrographs were
processed with Gatan software.
Sub-cellular fractionation
Preparation of detergent-insoluble membranes on
sucrose gradient. Caco-2/TC7 cells were homogenized on
ice for 30 min in 2 ml of 10 mM Tris-HCl pH 8, 150 mM NaCl
buffer (TN) containing 1% Triton X100 or in 2 ml of 20 mM
Tris-HCl pH 7.8, 250 mM sucrose, 1 mM CaCl2 and 1 mM
MgCl2 without detergent [32]. Anti-protease cocktail and anti-
phosphatases (orthovanadate and beta-glycerophosphate) were
added in both conditions. The cell homogenate was then adjusted
to 40% sucrose by addition of 2 ml sucrose (80% in TN). The
resulting 4 ml were covered with 4 ml of 30% sucrose and 4 ml of
5% sucrose and centrifuged for 16 h (39,000 rpm, 4uC) in a SW-
41 rotor (Beckman Instruments, Gagny, France). Sequential 1 ml
fractions were then collected from the top of the tube and the
turbid fraction containing the floating detergent-insoluble
membranes (fraction 4) was adjusted to 11 ml in TN buffer and
centrifuged in a SW-41 rotor (35000 rpm, 1h). The pellet was
dissolved in TN buffer containing 1% NP40, anti-proteases and
anti-phosphatasesandstored at 280uC until immunoprecipitations.
Nuclei and crude membrane preparations. Proliferating
or polarized/differentiated Caco-2/TC7 cells were washed twice
in 10 mM Tris-HCL pH 7.5 containing 20 mM KCl, 2 mM
CaCl2, 2 mM MgCl2 and 0.2 mM spermidine (TKCM buffer)
and scrapped in TKCM containing 1% Triton X-100, 1 mM
phenylmethylsulfonylfluoride (PMSF), anti-proteases and anti-
phosphatases. Nuclei were pelleted by centrifugation at 1000g
for 10 min at 4uC and supernatants corresponding to cytosolic and
membrane proteins were stored at –80uC until analysis. The
pellets were washed in TKCM buffer and nuclear proteins were
extracted with 2M NaCl in TKCM buffer for 1h at 4uC. Excess
NaCl was removed by overnight dialysis against PBS at 4uC.
Immunoprecipitation and immunoblotting analyses
The raft fractions were immunoprecipitated with rabbit anti-
PrP
c (Ab 703) polyclonal antibodies, or non-specific rabbit
immunoglobulins or anti-pan desmoglein antibodies coupled to
protein A-sepharose 4B (Amersham Biosciences, Orsay, France).
For SDS-PAGE, samples were boiled for 10 min in Laemmli
buffer (2.5% SDS final concentration) and fractionated under
reducing conditions in polyacrylamide gel. Proteins were trans-
ferred onto nitrocellulose membranes (Bio-Rad), blocked 2h with
5% non-fat dried milk in TBS/0.1% Tween 20 (TBST). After two
washes in TBST, membranes were incubated (1h at room
temperature) with specific antibodies. After three washes in TBST,
the membranes were incubated (1h at room temperature) with
peroxidase-labelled (HRP) secondary antibodies (Amersham
Biosciences) in TBST. After three washes in TBST, bound
antibodies were detected by chemiluminescent method (ECL,
Amersham Biosciences). The quantitative analyses were per-
formed with a high performance calibrated imaging densitometer
(Bio-Rad GS-800) using PD Quest and Image Quant 5.2
softwares.
GPI anchor detection. After SDS-PAGE of immunopreci-
pitated materials and transfer onto nitrocellulose, membranes were
incubated two hours in a binding buffer (50 mM NaH2PO4/0.3%
Tween 20) before addition of biotinylated pro-aerolysin bacterial
toxin. Biotinylated proteins were detected by blotting with HRP-
conjugated streptavidin.
Endo F treatment. Nuclear proteins and rafts extracts were
treated with Endoglycosidase F (10 units/50 mg proteins) in
40 mM sodium phosphate buffer, pH 7.5 containing 0.4% SDS,
20 mM DTT and 0.8% NP40 for 16 hours at 37uC before
immunoblot analysis.
MS analysis
SDS/PAGE separation and protein digestion. Raft
fractions were immunoprecipitated with anti PrP
c antibodies and
separated on 4–12% SDS/polyacrylamide gels. After staining with
colloidal Commassie blue (G250, Bio-Rad), the visualized bands
were cut into slices of 1 mm. Gel slices were then reduced,
alkylated and subjected to digestion with trypsin (Roche
Diagnostics) as already described [33]. Extracted peptides were
dried and solubilized in solvent A (95/5 water/acetonitrile in 0.1%
(w/v) formic acid). The total digestion product of a gel slice was
used per liquid chromatography-tandem MS (MS/MS) analysis.
Liquid chromatography-MS/MS analysis. The extracted
peptides were concentrated and separated on a LC-Packing system
(Dionex S.A.) coupled to the nano-electrospray II ionisation
PrPc and Epithelial Cells
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PicoTip (10 mm i.d., New Objectives, Woburn, MA). The MS/
MS data was searched twice by using MASCOT (Matrix Science,
London) and PHENYX (Geneva Bioinformatics S.A.) softwares on
internal servers, first without taxonomic restriction to reveal the
presence of proteins of interest and mammalian contaminants,
then again the National Center for Biotechnology Information
Human database (National Library of Medicine, Bethesda). All
data are manually verified in order to minimise the errors in
protein identification and/or characterization.
Statistical analysis
Statistical analyses were performed using student’s t test.
Results
The cellular prion protein is localized in the nucleus in
dividing cells and in cell–cell junctions in polarized
epithelial cells
We analyzed, by immunofluorescence and immunoelectron
microscopy, the distribution of PrP
c or of GFP-PrP
c in
exponentially growing or polarized Caco-2/TC7 enterocytes.
Representative images of PrP
c, E-cadherin and DAPI labeling of
the nuclei in exponentially growing Caco-2/TC7 cells (day 3) are
shown in Figure 1A. When cells have not yet established well-
defined adherens junctions, as shown by the poor expression of E-
cadherin at cell–cell contacts (left panel), PrP
c was mainly detected
intracellularly. Interestingly, this staining co-localized with DAPI
labeling, in the nucleus (middle panel). Immunodetected PrP
c
appeared as dots that were distributed around the nucleolus (right
panel). This localization was confirmed by immunoelectron
microscopy where the PrP
c signal appeared accumulated in the
nucleus (Fig. 1B, N) and systematically excluded from the
nucleolus (Fig. 1B, *). The nuclear localization of the transfected
mouse GFP-PrP
c at this stage of the culture further strengthened
the results obtained for the endogenous protein (Fig. 1C).
In confluent and polarized Caco-2/TC7 cells (day 10), when E-
cadherin-dependent junctions were established, PrP
c was detected
at the lateral membrane, and did not co-localize with DAPI in 90–
95% of the cells (Fig. 1D). GFP-PrP
c was also found targeted to the
lateral membranes of polarized cells (Fig. 1E). This PrP
c
localization was previously revealed by immunoelectron micros-
copy [24]. As cells were not synchronized, PrP
c was found in the
nucleus in the few dividing cells (5–10%) that were still present
within the confluent cell layer. In all conditions, a significant
proportion of trafficking PrP
c, which corresponded to approxi-
mately 30–40% of the total protein, was also observed in the
cytoplasm.
The cellular prion protein is differently localized in
proliferative and differentiated compartments of human
intestinal epithelium
The sub-cellular localization of PrP
c was analyzed in human
intestinal epithelium and compared in crypts and villi, which
correspond to the proliferative and differentiated compartments,
respectively. In crypts, PrP
c was found to co-localize with Ki-67, a
nuclear marker of dividing cells (Fig. 2A). By contrast, in the crypt-
villus transition compartment (Fig. 2B) and in villi (Fig. 2C), i.e. as
soon as the process of cell division is stopped and the
differentiation takes place, the nuclei, visualized by DAPI, were
found devoid of Ki67 and of PrP
c, which was visualized in the
cytoplasm and in the lateral membranes of adjacent cells.
Nuclear and junctional PrP
c isoforms exhibit similar post-
translational modifications but differ in their stability
The differential sub-cellular localization of PrP
c could result
from different molecular properties of the protein. Thus, we first
compared the stability of PrP
c when localized in the nucleus or in
the lateral membranes. The amount of PrP
c was determined by
western blot, in nuclear extracts from proliferative cells (day 3) and
membrane PrP
c-containing raft domains from differentiated Caco-
2/TC7 cells (day 10), at different times after inhibiting translation
by cycloheximide. Results reported in Figure 3A show that PrP
c is
much more stable when localized in the nucleus, where
degradation could not be observed over a 3 hour period, than at
the membrane, where 50% of the protein were degraded at
30 min.
PrP
c is submitted to post-translational modifications such as N-
linked glycosylation and addition of a GPI anchor. Endo F
treatment of nuclear or raft extracts resulted in an equivalent shift
of PrP
c bands, demonstrating that nuclear and raft PrP
c are
similarly N-glycosylated (Fig. 3B). Analysis of the presence of a
GPI anchor was performed on PrP
c immunoprecipitated by the
specific polyclonal rabbit antibodies Ab 703, using the biotinylated
pro-aerolysin bacterial toxin, which recognizes GPI anchors [29].
A specific band corresponding to the presence of a GPI anchor on
PrP
c was detected in both nuclear and raft extracts (Fig. 3C,
middle panel), at the same molecular weight as the PrP
c signal
(Fig. 3C upper panel), i.e. at 30 kDa. The absence of
contamination of the nuclear and raft extracts with proteins
derived from the other compartment was verified. Calnexin
protein, which is known to be regularly buoyed with rafts [34] and
the poly-(ADP-ribose) polymerase (PARP) protein that is exclu-
sively expressed in the nucleus were used as markers of the
respective compartments (Fig. 3C, lower panels).
Junctional PrP
c is part of a complex involving
desmosome-associated proteins and c-Src, and interacts
with the structural proteins actin and annexin A2
A proteomic analysis was undertaken to determine the partners
of PrP
c in the junctional domains of enterocytes. Results presented
in table 1 showed that the membrane PrP
c interacts with five
desmosome-associated proteins, among which desmoglein, plako-
globin and desmoplakin, and with gamma- and beta-actin and
annexin A2, a structural protein that is known to participate in the
regulation of actin cytoskeleton dynamics in junctions of epithelial
cells [35]. The interaction with the desmosomal proteins and with
annexin A2 was corroborated by western blots after purification of
rafts in the presence of detergent and immunoprecipitation of PrP
c
by the specific rabbit polyclonal antibodies Ab 703 (Fig. 4A). Same
results were obtained with rafts purified, after sucrose gradients,
from cell extracts prepared without detergent (not shown). The
absence of interaction between E-cadherin and PrP
c [24] was
confirmed, since E-cadherin was recovered exclusively in the
immunoprecipitation supernatant (Fig. 4B). Interestingly, besides
the already reported interaction of c-Src with the junctional PrP
c
[24], the immunoprecipitation of raft fraction with the anti-
transmembrane protein desmoglein antibody revealed a complex
including c-Src, desmoglein, and PrP
c (Fig. 4C), while, as
expected, desmoglein and E-cadherin did not interact.
PrP
c invalidation impairs the sub-cellular localization of
junction-associated proteins and desmosome structure
Based on its interaction with desmosomal proteins, studies were
undertaken to determine whether PrP
c could be involved in the
organization of cell–cell junctions. Enterocytes were thus treated
PrPc and Epithelial Cells
PLoS ONE | www.plosone.org 4 August 2008 | Volume 3 | Issue 8 | e3000with human PrP
c-siRNA, before the onset of cell polarity and the
formation of cell–cell junctions. A kinetic analysis of PrP
c levels in
transfected cells, by immunofluorescence, showed that in 50 to
60% of the cells the levels of the endogenous PrP
c were
dramatically decreased 2 days (not shown) or 3 days after
transfection (Fig. 5A) as compared to control cells, i. e. cells
transfected with an inefficient mouse PrP
c-siRNA or with a
scramble siRNA or cells incubated with Oligofectamine only, and
returned to the control levels from 4 days after transfection (not
shown).
Figure 1. Expression and localization of PrP
c in proliferating or differentiated/polarized Caco-2/TC7 cells. Immunofluorescence
labeling of PrP
c (red, 12F10 antibody) and E-cadherin (green) was performed after 3 (A, left panel) or 10 (D, left panel) days in culture. Nuclei were
stained with DAPI (A, middle and right panels, D, right panel). Right panels in A represent an enlargement of a typical nuclear labeling of one cell (*,
nucleolus). Note that left panels correspond to a cluster of three cells and middle panels to a cluster of 13 cells. (B): Immunoelectron microscopy of
PrP
c was performed on day 3. (N, nucleus; *, nucleolus). (C, E): Sub-cellular localisation of GFP-PrP
c was analyzed on day 3 or 10 and compared with
DAPI staining (right panels). Note the absence of PrP
c and of E-cadherin, used as a marker of the junctional state, at the cell–cell contacts of
proliferative cells (A) and their presence in the lateral membranes of polarized/differentiated cells as shown in XY (upper panels D) and XZ (lower
panel D) planes. Bars: (A) 10 mm for left panels, 20 mm for middle panels and 4 mm for right panels, (B) 1 mm, (C and E) 10 mm and (D) 20 mm.
doi:10.1371/journal.pone.0003000.g001
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after transfection by the analysis of the expression and localization
of E-cadherin, which does not interact with PrP
c but is the most
studied marker of cell–cell junctions. Three days after transfection
(i.e 6 days after seeding), junctional complexes were already
formed in the center of expanding cell clusters. In cells where PrP
c
expression was specifically impaired, the E-cadherin still localized
to the lateral membranes of adjacent cells but its labeling intensity
was decreased (Fig. 5A). Moreover, in the same fields, the cells
appeared enlarged as compared with the three control conditions,
as clearly noticeable in phase contrast picture (Fig. 5A). When the
effect of human siRNAs on the expression of PrP
c was no longer
observed (day 7, Fig. 5A), the size of the cells and the amount of
the junctional E-cadherin were rescued. We then analyzed the
expression and the sub-cellular localization of the junctional
partners of PrP
c by immunofluorescence (Fig. 5B). To better
compare cells that still expressed PrP
c (40–50%) or not (50–60%),
fields that combined the two cell populations of human PrPc-
siRNA transfected cells are shown (Fig 5B, right panels) along with
pictures representative of the results obtained in the three control
conditions (Fig. 5B, left panels). Cells exhibiting a net decrease of
PrP
c levels were systematically enlarged. In these cells, the amount
and/or the sub-cellular localization of the junctional partners of
PrP
c were modified: c-Src was found essentially intracellular,
Figure 2. Expression and localization of PrP
c and Ki67 in normal human intestinal epithelium. Immunofluorescence labeling of PrP
c
(green, 12F10 antibody) and Ki67 (red) was performed on thin sections of paraffin-embedded pieces of jejunum. Images in A, B and C correspond to
crypts, crypt-villus transition compartment and villus respectively, as indicated on the scheme. Lower panels in A correspond to an enlargement of
the crypt zone shown above. In B and C, nuclei were stained with DAPI. Note the colocalization of PrP
c and Ki67 in the nuclei of crypt cells and the
cytoplasmic and membrane localization of PrP
c in Ki67 negative epithelial cells. LP, lamina propria; L, lumen. Arrows point out cell–cell junctions of
the epithelium. Bars: 20 mm.
doi:10.1371/journal.pone.0003000.g002
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and numerous actin stress fibers could be visualized in large cells
that no longer expressed PrP
c.
The role of PrP
c on structural organization of cell–cell junctions
was further analyzed in intestinal epithelium of PrP
c knock out
mice. Ultrastructural analysis revealed drastic changes in the
length of the desmosomal plaque (Fig. 5C upper panel), which was
not compensated by their number (not shown). Quantification of
the length of desmosomes indicated a distribution of their size
concentrated between 83 to 134 nm in knock out mice instead of
100 to 183 nm in wild type mice (Fig. 5C lower panel).
PrP
c invalidation impairs completion of cell division and
results in a shortening of intestinal villi
When compared to the three control conditions, we noticed an
enlargement of human PrP
c siRNA-treated dividing enterocytes
(Fig. 5A) that could reflect the impact of PrP
c-expression on cell
proliferation. Analysis of cell growth (Fig. 6A) showed an arrest of
the increase in cell numbers between 2 and 3 days after
transfection, i.e during the period when PrP
c expression was
significantly decreased by human siRNAs. Surprisingly, DAPI
staining of the nuclei showed that growth arrest was paralleled
with a net increase of the number of mitosis, without apoptosis, in
cells that did not express PrP
c anymore (Fig. 6B). In parallel, the
morphological examination of the intestinal epithelium of PrP
c
knock out mice revealed a net decrease in the length of the villi in
both duodenum and jejunum segments in comparison with their
wild type counterparts (Fig. 6C). To analyze the impact of PrP
c
expression on cell proliferation within the intestinal epithelium,
PrP
c knock out and wild type mice were pulse-labeled with BrdU
for 1.5 hour prior to sacrifice. No significant difference in the
number of BrdU-labeled cells in sections of jejunal crypts was
observed between wild type and knock out mice (Fig. 6D),
suggesting that S phase was not affected. By contrast, labeling of
the mitosis-associated phospho-H3 revealed a net increase of
mitotic cells in the crypt compartments of intestine from PrP
c
knock out mice as compared with wild type mice, while no obvious
change in the size of the crypts was observed.
Figure 3. Biochemical characterization of membrane- and nucleus-associated PrP
c isoforms. (A): Stability of membrane and nuclear PrP
c
was analyzed by western blot after treatment of the cells with cycloheximide for the indicated times and purification of membranes and nuclei. Bands
obtained in western blots (SAF 32 antibody) were quantified by scanning densitometry. E-cadherin and PARP were used to normalize the values
obtained in membrane and nuclear fractions respectively, since both proteins were found stable for the duration of CHX treatment. Histograms
correspond to the ratio (%) between PrP
c and E-cadherin or PARP from the corresponding scanned bands at each time (mean6SD from 3
independent experiments), the value obtained at time 0 being set at 100. (B): To determine the glycosylation state, rafts and nuclear extracts were
treated (+) or not (2) with endo F and PrP
c was analyzed by western blot (SAF 32 antibody). Molecular weight in KDa are indicated (C): The presence
of a GPI anchor was analyzed after immunoprecipitation of PrP
c from rafts or nuclear extracts, SDS-PAGE, transfer and overlay with biotinylated pro-
aerolysin bacterial toxin. To check the purity of the extracts, the expression of calnexin (membrane marker) and PARP (nuclear marker) was analyzed
by western blot. Molecular weight in KDa are indicated.
doi:10.1371/journal.pone.0003000.g003
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Our present results demonstrate that the cellular prion protein,
PrP
c, exhibits a dual distribution between the nucleus, in actively
dividing cells, and cell–cell adhesion sites in polarized/differentiated
cells. Interestingly, the membrane PrP
c interacts with desmosomal
proteins as well as with actin and actin-binding proteins at cell–cell
junctions. Furthermore, we show that down regulation of PrP
c
expression in Caco-2/TC7 enterocytes lead to a complex pattern of
alterations in both cell architecture and completion of the cell
division process. These results are strengthened by the analysis of
the intestinal epithelium of PrP
c knock out mice, in which intestinal
villi were found shortened and the size of enterocyte desmosomes
decreased as compared to wild type mice.
Contrary to abnormal prion proteins [36–38], a targeting of the
normal PrP
c isoform to the nucleus has been rarely reported,
[39,40]. We demonstrate here that in intestinal epithelial cells, such
a nuclear targeting is observed only in actively dividing cells, both in
cultured enterocytes and in the intestinal epithelium in vivo.T h e
characterization of the nuclear pattern of PrP
c isoforms revealed
that it is similar to that of membrane-associated PrP
c in terms of
glycosylation and presence of a GPI anchor. Analysis of protein
stability shows a much longer half-life of PrP
c in the nucleus than in
plasma membrane, where junctional proteins are rapidly recycled.
Nuclear PrP
c stability could rely on the association with particular
sub-nuclear compartments, such as PML bodies [41], a localization
compatible with the pattern of nuclear PrP
c staining that we
observed. Contrasting with the misfolded protein [38], we show an
exclusion of normal PrP
c from the nucleolus. Altogether, our results
asked the question of its biological role in the nucleus of dividing
cells. Upon PrP
c down regulation in cultured enterocytes, we
observed modifications of cell morphology and an arrest of cell
growth. This observation was consistent with the decreased villus
size of the intestinal epithelium that we observed in PrP
c null mice.
In several mouse models, it has been shown that reduced intestinal
crypt cell proliferation is associated with shorter villi [42,43]. The
growth arrest observed in PrP
c siRNA-transfected cells was
paralleled by an increase of mitotic cells. Further analysis of cell
cycle perturbations was rendered difficult by the moderate
transfection efficiency of Caco-2/TC7 cells by siRNA (50%).
Nevertheless, the absence of S phase overt perturbation in crypts
from PrP
c null mice, as shown by BrdU incorporation experiments,
along with the important increase of the number of mitotic cells in
the crypt compartment suggest that PrP
c invalidation would affect
the mitosis process. PrP
c has been shown to associate with tubulin
[44] [45]. In addition, desmoplakin, that we identified as a PrP
c
partner, participates to the organization of microtubules in
keratinocytes, through the recruitment at cell–cell junctions of a
centrosomal protein, which is required for microtubule anchoring
[46]. However, it cannot be concluded yet whether all the phases of
mitosis or more particularly the last step of cytokinesis are slowed
down through PrP
c invalidation.
Table 1. PrP
c partners in rafts.
Identified proteins Accession n
o. Mr
Peptide
matches
Desmoglein 2 gi 416178 122 9
Plakophilin 2a gi 1871541 93 4
Plakoglobin gi 15080189 82 9
Desmoyokin gi 627367 312 17
Desmoplakin gi 3702136 332 38
gamma-actin gi 17511847 42 8
beta-actin gi 16359158 42 10
alpha2 Spectrin gi 1805280 285 10
Annexin isoform 2 gi 16306978 39 18
Raft extracts from differentiated Caco-2/TC7 cells (10 days) were
immunoprecipitated with anti PrP
c antibodies. The presence of PrP
c in the
resulting material was checked by western blot before identification of the
proteins interacting with PrP
c by liquid chromatography-tandem MS (MS/MS).
The number of peptide matches that was obtained after trypsination for each
protein as well as the accession number (NCBI) and the molecular weight (Mr)
are reported.
doi:10.1371/journal.pone.0003000.t001
Figure 4. Immunodetection of PrP
c-associated desmosomal proteins in differentiated Caco-2/TC7 cells. (A): Proteins that were found to
interact with PrP
c through proteomic study (Table 1) were analyzed by western blot in rafts, and in immunoprecipitated material (IP) or in
supernatants of immunoprecipitations (S-IP) from raft extracts of differentiated cells (day 10). Immunoprecipitations were performed with rabbit anti-
PrP
c antibodies (Ab703) or with non-specific rabbit immunoglobulins as a control. (B): The presence of E-cadherin, which was not identified as a PrP
c
partner, was checked, after immunoprecipitation with anti-PrP
c, in immunoprecipitated material (IP) and immunoprecipitation supernatant (S-IP).
Note that E-cadherin is only recovered in immunoprecipitation supernatant. (C): desmoglein (Dsg), Src, PrP
c and E-cadherin (E-cad) were analyzed by
western blot in raft extracts (right lane) or after their immunoprecipitation with anti-desmoglein antibodies (left panel). Note the co-
immunoprecipitation of desmoglein, c-Src and PrP
c and the absence of E-cadherin co-immunoprecipitation.
doi:10.1371/journal.pone.0003000.g004
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c invalidation on the sub-cellular localization of junctional PrP
c partners and on desmosome structure. (A):
Caco-2/TC7 cells were transfected by PrP
c-siRNA 3 days after seeding and the expression and localization of PrP
c (red, 12F10 antibody) and E-cadherin
(green) were analyzed 3 days and 7 days after transfection in control (Oligofectamine or mouse PrP
c-siRNA transfected cells) or human PrP
c-siRNA
transfected cells. Phase contrast image (phase) shows the morphology of the cell layer. (B): Immunofluorescence labeling of PrP
c (red), c-Src,
desmoglein, plakoglobin, desmoplakin and F-actin (green) was performed in control cells (left panels) and in human PrP
c-siRNA transfected cells 3
days after transfection (right panels). Control pictures are representative of the results obtained with scramble siRNA or with mouse PrP
c si-RNA or
with cells incubated with the transfection agent, Oligofectamine. In human PrP
c-siRNA transfected cells, fields combining zones where PrP
c was still
present (open arrowhead) and zones where it was switched off (closed arrowhead) are shown. Note the difference in cell shape between both areas.
Mouse 12F10 anti-PrP
c antibody was used for immunofluorescence labeling of PrP
c except for co-labeling with plakoglobin, in which rabbit
polyclonal anti-PrP
c Ab703 antibodies were used. Bar: 20 mm. (C): Desmosomes were analyzed by electron microscopy in intestinal epithelium
sections from PrP
c knock out (KO) and wild type (WT) mice. Note the electron-dense desmosomal plaque which was shorter in PrP
c-knock-out than in
wild type mice (arrowheads). mv: microvilli, TJ: tight junction, AJ: adherens junction. Bar: 100 nm. Quantification of desmosome size was represented
in the lower graph. Box and whisker plots show median desmosomal length (horizontal line), 25th and 75th centiles (box), and range (whiskers) in the
wild type (WT, n=135, three mice) and PrP
c-knock out mice (KO, n=135, three mice), ***p,0.001.
doi:10.1371/journal.pone.0003000.g005
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c invalidation on the completion of cell division and length of intestinal villi. (A): Caco-2/TC7cells were numbered
all along the experiment from 3 days before transfection (23) to 7 days after transfection. Controls combine results obtained in the three conditions
described in figure 5 (scramble siRNA, mouse PrP
c si-RNA, Oligofectamine). PrP
c-siRNA condition corresponds to the results obtained after specific
human PrP
c-siRNA transfection. Results are from 4 independent experiments. **p,0.01, ***p,0.001. (B): In the same experiments, cells that showed
nuclear division phases were counted after staining with DAPI. In the left panels arrows point examples of metaphases or telophases that were
counted. In each condition, 1000 cells were analyzed and the percentage of mitotic cells in controls (black bar, same three conditions as above) or in
human PrP
c-siRNA (white bar) transfected cells is reported in the right panel. Error bar shown in histogram of controls represents the statistical
analyses performed when combining the three control conditions. C: sections of duodenum and jejunum fragments from wild type (WT) and PrP
c
knock out (KO) mice (2 mice in each group) were stained with DAPI (right panel, bar: 100 mm). Sixty villi were measured for each mouse and fragment.
No difference was observed between the 2 mice of each group (not shown), but significant differences (***p,0.001) were obtained between wild
type (black bars) and knock out mice (white bars) in both duodenum and jejunum fragments. (D): After 1.5 hour BrdU intraperitoneal injection,
sections from the jejunum fragment of wild type (WT) and knock out (KO) mice were performed. Nuclei were visualized with DAPI staining (blue).
BrdU-stained proliferating cells (green) are limited to the crypts in wild type and knock out animals. Bars: 10 mm. Knock out mice display similar
number of positive BrdU cells per crypt as compared with wild type mice (quantification in the right panel graph). No significant difference was
revealed by statistical analysis (ns, student’s t test). (E): Immunofluorescence analyses of phospho H3 (green) and E-cadherin (red) were performed on
intestine sections from wild type (WT) or PrP
c knock out (KO) mice (3 mice in each group). Pictures of crypt staining are shown (upper panels; bars:
10 mm) and the number of phospho-H3 positive cells per crypt is reported (155 crypts were counted in each group). ***p,0.001.
doi:10.1371/journal.pone.0003000.g006
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desmosomal proteins as PrP
c partners at cell–cell junctions. We
had already identified c-Src kinase as a partner of PrP
c in
polarized enterocytes and demonstrated that PrP
c does not
interact with E-cadherin [24], asking the question of the partner
that could link PrP
c, which is anchored in the outer leaflet of the
lateral membrane, to Src, which is localized in the inner one. Our
data are consistent with the existence of a molecular complex in
which the transmembrane desmosomal cadherin desmoglein is this
link between PrP
c and c-Src. Involvement of PrP
c in the regulation
of desmosome organization, and more generally in cell architec-
ture, is further supported by our demonstration of alterations in
the junctional targeting of Src and desmosomal proteins upon PrP
c
down-regulation by siRNA during the establishment of enterocyte
cell–cell contacts. Importantly, absence of PrP
c in vivo results in
alterations in the size of desmosomes in intestinal epithelial cells.
This structural perturbation could reflect modifications of
assembly and/or stability of the desmosomal-protein complex in
the absence of PrP
c, as described for invalidation or mutation of
other desmosome-associated proteins, such as desmoglein, plako-
globin or plakophilin families, in murine models or human
pathologies (for review, see [47]). Desmosomal proteins have
emerged as adhesion molecules that not only play critical
structural roles but are also involved in signaling pathways [48].
Our data further support the hypothesis of the involvement of
PrP
c, in association with its desmosomal partners, in a signaling
platform of the junctional state.
In conclusion, our results indicate that the normal cellular prion
isoform PrP
c, by its differential nuclear or junctional localization,
must be considered as a potential actor of the balance between
proliferation and polarization/differentiation of epithelial cells,
through interaction with c-Src and with desmosome- and
cytoskeleton-associated proteins. As such PrP
c could be involved
in the homeostasis of renewing epithelia.
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